Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,236.00    -2.00 (-0.16%)
Bid:
1,239.00
Ask:
1,240.00
Spread: 1.00 (0.081%)
Market Cap: £854.29m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Exercise of Options, Directors' Dealing and TVR

5 Nov 2018 08:05

RNS Number : 3140G
CVS Group plc
05 November 2018
 

05 November 2018

 

CVS Group plc

("CVS" or the "Company")

 

Exercise of Options, Directors' Dealing and Total Voting Rights

CVS, the UK's leading provider of integrated veterinary services, announces that on 2 November 2018, Simon Innes Chief Executive of the Company, together with certain other employees and a former employee of the Company, exercised options at 0.2 pence per share over an aggregate of 146,000 ordinary shares of 0.2 pence each in the Company (the "New Shares"), under the CVS Group Long Term Incentive Plan 2015/2018. Simon Innes exercised options over 57,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares").

 

Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 8 November 2018.

 

Following the issue of the New Shares, the Company's total issued share capital will consist of 70,519,031 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company will be 70,519,031. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

On 1 November 2018, the Company was notified that, on that date, Simon Innes sold 57,000 Ordinary Shares at a price of £9.10 per Ordinary Share. Following the exercise and the sale, Simon Innes remains interested in 255,266 Ordinary Shares in the Company, representing 0.36 per cent of the total voting rights of the Company following the issue of the New Shares.

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

 

Contacts:

 

CVS Group plc

Simon Innes, Chief Executive

Richard Fairman, Finance Director

 

Tel: 01379 644 288

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Jen Boorer

 

Tel: 020 7496 3000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Simon Innes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Option Exercise

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

0.2 pence

57,000

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

57,000 Ordinary shares

 

 

£114.00

e)

 

Date of the transaction

 

 

[DATE]

f)

Place of the transaction

[PLACE]

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Simon Innes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Sale of ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

910p

57,000

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

57,000

 

 

£518,700

e)

 

Date of the transaction

 

 

02 November 2018

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBABPTMBMMMJP
Date   Source Headline
10th Jul 20264:28 pmRNSHolding(s) in Company
6th Jul 20267:00 amRNSTransaction in Own Shares
3rd Jul 20264:38 pmRNSStandard form for notification of major holdings
1st Jul 20264:53 pmRNSStandard form for notification of major holdings
30th Jun 20264:21 pmRNSStandard form for notification of major holdings
30th Jun 202610:59 amRNSStandard form for notification of major holdings
30th Jun 20267:00 amRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20269:48 amRNSStandard form for notification of major holdings
15th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.